Celiac disease clinical trials

Explore recruiting celiac disease clinical trials.

Recruiting celiac disease studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Celiac disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase II, Double-Blind, Randomised, Placebo-Controlled Trial to Evaluate the Efficacy and Tolerability of ZED1227 in Celiac Disease Subjects Experiencing Symptoms Despite Gluten-Free Diet

Norway, Sweden, Austria, Poland, Germany, Finland +4 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2a Trial to Characterize the Efficacy and Safety of TEV-53408 in Adults with Celiac Disease While Undergoing Oral Gluten Exposure

Finland

Therapeutic exploratory (Phase II) EU CTIS Study details

KAN-101-03: A Phase 2a Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of KAN-101 In Participants With Celiac Disease

Finland, Ireland, Poland, Germany, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 1b Study to Characterize the Safety and Tolerability of TEV-53408 in Adults with Celiac Disease

Finland

Human Pharmacology (Phase I)- Other EU CTIS Study details

Clinical trial to evaluate the correlation between variation in intestinal lactase activity measured with LacTEST 0.45g and alteration of intestinal barrier integrity and/or intestinal permeability in patients with celiac disease

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Anti-viral action against Type 1 diabetes autoimmunity GPPAD-05-AVAnT1A

Poland, Sweden, Belgium, Germany, Austria, Italy

Therapeutic use (Phase IV) EU CTIS Study details

Celiac disease trials by city

Celiac disease in Toronto Celiac disease in Vancouver Celiac disease in Montreal Celiac disease in Calgary Celiac disease in Edmonton Celiac disease in Ottawa Celiac disease in Winnipeg Celiac disease in Quebec City Celiac disease in Hamilton Celiac disease in Kitchener Celiac disease in London Celiac disease in Halifax Celiac disease in New York Celiac disease in Los Angeles Celiac disease in Chicago Celiac disease in Houston

Other conditions

Alcohol use disorder Substance use disorder COPD Asthma Long COVID Cystic fibrosis Pulmonary fibrosis Sleep apnea Chronic cough Crohn's disease Ulcerative colitis Irritable bowel syndrome GERD Eosinophilic esophagitis Gastroparesis Rheumatoid arthritis Lupus Psoriatic arthritis Ankylosing spondylitis Osteoarthritis Knee osteoarthritis Osteoporosis Sjogren's syndrome Scleroderma